|
Prescription Drug Search
Product Request Form
Folotyn is currently not available.
Our suppliers are constantly updating their product inventory and availability status. If you would like us to notify you when Folotyn becomes available, please fill out the form below.
*We value your privacy! We will never give, lease, sell or otherwise disclose your personal information. Period!
Browse Alphabetically:
A
·
B
·
C
·
D
·
E
·
F
·
G
·
H
·
I
·
J
·
K
·
L
·
M
·
N
O
·
P
·
Q
·
R
·
S
·
T
·
U
·
V
·
W
·
X
·
Y
·
Z
·
#
Information about CancerDrugsDirect.com
List of countries where we can ship Folotyn:
- Albania
- Anguilla
- Antigua and Barbuda
- Argentina
- Australia
- Azerbaijan
- Bangladesh
- Barbados
- Bosnia and Herzegovina
- Brazil
- Bulgaria
- Cayman Islands
- Costa Rica
- Cuba
- Cyprus
- European Union
- Germany
- Greece
- Grenada
- Guatemala
- India
- Italy
- Jordan
- Korea, Republic of
- Kuwait
- Luxembourg
- Moldova, Republic of
- Morocco
- Portugal
- Qatar
- Romania
- Saint Lucia
- Serbia
- Sweden
- Taiwan
- Trinidad and Tobago
- United Kingdom, UK
- United States, US
- Venezuela
- Yemen
Latest news releases on Folotyn:
Spectrum Pharmaceuticals Reports Record Revenues and Profits for First Quarter of 2012 - Boston Globe
FOLOTYN may suppress bone marrow function, manifested by thrombocytopenia, neutropenia, and anemia. Monitor blood counts and omit or modify dose for hematologic toxicities. Mucositis may occur. If greater-than or equal to Grade 2 mucositis is ...
Spectrum, Allos announce extension of previously announce tender offer - Yahoo Finance
which entitles Allos stockholders to an additional payment of $0.11 per share in cash if certain European regulatory approval and commercialization milestones for FOLOTYN® are achieved.
Allos (ALTH) Sees Increased Volatility; FTC Requests More Info on Merger with Spectrum (SPPI) - StreetInsider.com
which entitles Allos stockholders to an additional payment of $0.11 per share in cash if certain European regulatory approval and commercialization milestones for FOLOTYN are achieved. The offer, which was previously scheduled to expire at 12:00 midnight ...
Spectrum Pharmaceuticals and Allos Therapeutics Announce Extension of Previously Announced Tender Offer For Shares of Allos Therapeutics - Stockhouse
Allos is currently focused on the development and commercialization of FOLOTYN ® (pralatrexate injection), a folate analog metabolic inhibitor. FOLOTYN is approved in the U.S. for the treatment of patients with relapsed or refractory peripheral T-cell ...
Increased Mammograms Up to 65% Responsible for Breast Cancer Mortality Reduction - msnbc.com
Pralatrexate (Folotyn), Raloxifene (Evista), Ramucirumab, Ridaforolimus (MK-8669), Sorafenib (Nexavar), Trastuzumab (Herceptin), Trastuzumab biosimilar, Trastuzumab emtansine (T-DM1), Trilostane, Triptorelin, TVAX cancer vaccine, Varlitinib ...
BUYINS.NET: Market Maker Surveillance Report. CPWM, THC, ALTH, CSCO, … - TMCnet
It is developing FOLOTYN (pralatrexate injection), a folate analogue metabolic inhibitor, for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma. The company is also developing FOLOTYN as a single agent and in ...
